Dangers of Herpesvirus Infection in SLE Patients Under Anifrolumab Treatment: Case Reports and Clinical Implications

Mads Lamm Larsen; Morten Kelder Skouboe; Trine Hyrup Mogensen; Alex Lund Laursen; Bent Deleuran; Anne Troldborg; Mads Nyhuus Bendix Rasch

doi:10.12659/AJCR.944505

09 September 2024 : Case report Denmark

Dangers of Herpesvirus Infection in SLE Patients Under Anifrolumab Treatment: Case Reports and Clinical Implications

Unusual clinical course, Adverse events of drug therapy

Mads Lamm Larsen

^12ABCDEF*, Morten Kelder Skouboe

^23ABCDEF, Trine Hyrup Mogensen

^23ABCDEF, Alex Lund Laursen

^3ABCDEF, Bent Deleuran

^12ABCDEF, Anne Troldborg

^124ABCDEF, Mads Nyhuus Bendix Rasch^1ABCDEF

DOI: 10.12659/AJCR.944505

Am J Case Rep 2024; 25:e944505

Authors information Article notes Copyright and License information

Introduction Case Reports Case 2 Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Computed tomography scan of the liver in Case 1. Herpes simplex virus 2 hepatitis with millimetric hypodensities resembling multiple hepatic micro abscesses (arrows) is shown.

Back to the Article

Dangers of Herpesvirus Infection in SLE Patients Under Anifrolumab Treatment: Case Reports and Clinical Implications

Your Privacy